Accepted answer
Clearance is at least five sequential decisions, and the eleven-day silence is usually the first or second one, not the customs officer. Understanding the sequence tells you which delays are meaningful.
The pipeline
- Outbound consolidation. The shipper hands the parcel to a consolidator, which waits for a container to fill and a slot on a flight. Tracking often shows nothing useful during this stage, and it can be a week on its own. This is the single most common cause of "stuck at origin" and it has nothing to do with any authority.
- Advance electronic data screening. Before the aircraft lands, the destination receives manifest data: shipper, consignee, description, weight, declared value, HS code. Risk engines score it. This is where most decisions are made and no human sees most parcels.
- Non-intrusive inspection. Selected parcels get X-rayed. Density anomalies, dense uniform blocks, and the classic vacuum-sealed-mass signature draw attention. A vial of lyophilised powder is not itself alarming; twenty identical vials in foil with no paperwork is a pattern.
- Physical examination and, if warranted, referral. Opened, described, and possibly field-tested. If it appears to be a medicinal product or an unapproved drug, it is referred to the health regulator rather than decided by the border agency.
- Admissibility determination and duty/tax assessment. Two separate questions. A parcel can be admissible and still generate a bill.
What the risk engine actually weights
- Description-to-value coherence. The most productive single signal. A description that cannot plausibly be worth the declared value, or vice versa, scores badly. This is why the "declare it as a five-dollar gift" advice is worse than useless — it maximises the mismatch that the system is specifically built to find, while also being a false statement.
- HS code and description mismatch. A generic code with a specific description, or the reverse, is a flag.
- Shipper history. Consolidators and originating addresses accumulate profiles. This is why identical parcels behave differently: the shipper's recent history changed, not yours.
- Consignee history. Repeat volume to a residential address from the same origin is a pattern. Sequential parcels are correlated events, not independent ones.
- Route. Transhipment through certain hubs, and postal versus express channel, change which system assesses it and how much data it has.
- Missing data. An incomplete commercial invoice is a hold in itself, and often the entirety of a long, boring delay.
Writing an accurate declaration
The requirement is a truthful, specific description, an accurate value, and a correct classification. Taking those in turn:
Description. Describe what it physically is and what it is for, without inventing a status it does not have. For a small quantity of lyophilised peptide intended as a laboratory reference material, an accurate description reads like "laboratory reference material, lyophilised peptide, research use only, not for human or veterinary use, X mg". Every clause there is a fact. What you must not do is describe it as a cosmetic, a food supplement, a gift, or a medicine — the first three are false and the fourth invites a regulatory referral that is much harder to resolve than a duty assessment.
Value. The transaction value: what you actually paid, in the currency you paid it in, freight and insurance stated separately if the destination assesses on a delivered basis. Under-declaring is a customs offence in its own right, independent of whether the goods are admissible, and it converts a duty question into a fraud question. It is also frequently pointless, because the declared value is checkable against the shipper's records and, increasingly, against the payment data.
Classification. Peptides for laboratory use generally fall in the chemical chapters rather than the pharmaceutical chapter, and which heading applies depends on the substance and the presentation. Getting this wrong is normally a correctable error; declaring under the pharmaceutical chapter when it is not a medicinal product, or under a food chapter when it is not food, are both worse than a merely imprecise chemical heading.
Documentation. Include the commercial invoice, the certificate of analysis and a safety data sheet. A parcel with a COA and an SDS looks like what it says it is; a parcel with nothing looks like whatever the officer imagines. This is the highest-yield, lowest-cost thing available and most consignments do not do it.
The part people skip
None of this makes an inadmissible item admissible. If the destination treats the substance as an unapproved medicinal product, then a perfect declaration produces a swift, well-documented refusal instead of a slow one. The reason to declare accurately is that the alternative adds a separate offence to the same outcome. Know your own jurisdiction's rules before ordering rather than after — the next answer covers how the personal-use discretion differs by country, and it differs a lot.
edited 17 May 2025 by nadia_kowalczyk — corrected a unit error in the worked example
5The description-to-value coherence point matches everything I have seen. The cheap gift declaration is the single biggest tell. – nils_karlberg 22 days ago 4Including the SDS changed my clearance rate noticeably. It costs nothing and it makes the parcel legible. – Dr_Bram_Verhoeven 9 months ago 3Also true that most long silences are the consolidator. Two of mine had not left the origin country at all. – tandem_gradient 4 months ago add a comment